BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 21126627)

  • 1. Beta-blockers in hypertension.
    Ram CV
    Am J Cardiol; 2010 Dec; 106(12):1819-25. PubMed ID: 21126627
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of beta-blockers on glucose and lipid metabolism.
    Fonseca VA
    Curr Med Res Opin; 2010 Mar; 26(3):615-29. PubMed ID: 20067434
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Are tolerability concerns a class effect of beta-blockers in treating patients with hypertension?
    Kountz DS
    Postgrad Med; 2009 Jan; 121(1):14-24. PubMed ID: 19179810
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of vasodilating beta-blockers in patients with hypertension and the cardiometabolic syndrome.
    Taylor AA; Bakris GL
    Am J Med; 2010 Jul; 123(7 Suppl 1):S21-6. PubMed ID: 20609696
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Beta-blockers in the treatment of hypertension: are there clinically relevant differences?
    Weir MR
    Postgrad Med; 2009 May; 121(3):90-8. PubMed ID: 19491545
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Are we misunderstanding beta-blockers.
    Cruickshank JM
    Int J Cardiol; 2007 Aug; 120(1):10-27. PubMed ID: 17433471
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Atenolol as a comparator in outcome trials in hypertension: a correct choice in the past, but not for the future?
    Dahlöf B; Devereux RB; Kjeldsen SE; Lyle PA; Zhang Z; Edelman JM
    Blood Press; 2007; 16(1):6-12. PubMed ID: 17453746
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of nitric oxide in improving endothelial function and cardiovascular health: focus on nebivolol.
    Bakris GL; Basile JN; Giles TD; Taylor AA
    Am J Med; 2010 Jul; 123(7 Suppl 1):S2-8. PubMed ID: 20609695
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Why beta-blockers should not be used as first choice in uncomplicated hypertension.
    De Caterina AR; Leone AM
    Am J Cardiol; 2010 May; 105(10):1433-8. PubMed ID: 20451690
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nebivolol: a third-generation beta-blocker for hypertension.
    Cheng JW
    Clin Ther; 2009 Mar; 31(3):447-62. PubMed ID: 19393838
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Beta-blockers in the management of hypertension: focus on nebivolol.
    Wojciechowski D; Papademetriou V
    Expert Rev Cardiovasc Ther; 2008 Apr; 6(4):471-9. PubMed ID: 18402537
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discordant effects of beta-blockade on central aortic systolic and brachial systolic blood pressure: considerations beyond the cuff.
    Epstein BJ; Anderson S
    Pharmacotherapy; 2007 Sep; 27(9):1322-33. PubMed ID: 17723086
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Retrospective studies and prospects of therapy for hypertension].
    Maisch B; Brilla C; Kruse T; Noll B; Bethge C
    Herz; 1995 Dec; 20(6):370-89. PubMed ID: 8582697
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of the new beta-blockers in treating cardiovascular disease.
    Weber MA
    Am J Hypertens; 2005 Dec; 18(12 Pt 2):169S-176S. PubMed ID: 16373195
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Should beta-blockers be used to control hypertension in people with chronic kidney disease?
    Hart PD; Bakris GL
    Semin Nephrol; 2007 Sep; 27(5):555-64. PubMed ID: 17868793
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Optimizing treatment of diabetes and cardiovascular disease with combined alpha,beta-blockade.
    Bell DS
    Curr Med Res Opin; 2005 Aug; 21(8):1191-200. PubMed ID: 16083528
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The current state of beta blockers in hypertension therapy.
    Lardizabal JA; Deedwania PC
    Indian Heart J; 2010; 62(2):111-7. PubMed ID: 21180299
    [TBL] [Abstract][Full Text] [Related]  

  • 18. One size does not fit all: the role of vasodilating beta-blockers in controlling hypertension as a means of reducing cardiovascular and stroke risk.
    Basile JN
    Am J Med; 2010 Jul; 123(7 Suppl 1):S9-15. PubMed ID: 20609697
    [TBL] [Abstract][Full Text] [Related]  

  • 19. What is the role, if any, for beta-blockers as initial therapy for uncomplicated hypertension?
    Pedersen ME; Cockcroft JR
    Curr Opin Cardiol; 2009 Jul; 24(4):325-32. PubMed ID: 19417638
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The foundation role of beta blockers across the cardiovascular disease spectrum: a year 2009 update.
    Black HR; Greenberg BH; Weber MA
    Am J Med; 2010 Nov; 123(11):S2. PubMed ID: 21035578
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.